Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature

Background and Purpose: Idarucizumab achieves instant reversal of anticoagulation and enables intravenous thrombolysis (IVT) in dabigatran-treated acute ischemic stroke (AIS) patients. AIS in dabigatran-treated patients is a rare event, therefore the experience is limited. A review of all published...

Descripción completa

Detalles Bibliográficos
Autores principales: Frol, Senta, Sagris, Dimitrios, Pretnar Oblak, Janja, Šabovič, Mišo, Ntaios, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209294/
https://www.ncbi.nlm.nih.gov/pubmed/34149597
http://dx.doi.org/10.3389/fneur.2021.666086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209294/
https://www.ncbi.nlm.nih.gov/pubmed/34149597
http://dx.doi.org/10.3389/fneur.2021.666086

Ejemplares similares